Critical role of indoleamine 2,3-dioxygenase in tumor resistance to repeated treatments with targeted IFNγ

被引:23
作者
Gasparri, Anna Maria [1 ]
Jachetti, Elena [1 ]
Colombo, Barbara [1 ]
Sacchi, Angelina [1 ]
Curnis, Flavio [1 ]
Rizzardi, Gian-Paolo [2 ]
Traversari, Catia [2 ]
Bellone, Matteo [1 ]
Corti, Angelo [1 ]
机构
[1] Ist Sci San Raffaele, Canc Immunotherapy & Gene Therapy Program, Dept Oncol, I-20132 Milan, Italy
[2] MolMed SpA, Milan, Italy
关键词
D O I
10.1158/1535-7163.MCT-08-0538
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Targeted delivery of IFN gamma to tumors has been achieved by fusing this cytokine with GCNGRC, a tumor neovasculature homing peptide. Although the therapeutic efficacy of this protein (called IFN gamma-NGR) in animal models is greater than that of IFN-gamma, frequent administrations of IFN gamma-NGR may result in lower efficacy and tumor resistance. We investigated the role of indoleamine 2,3-dioxygenase (IDO), an IFN gamma-inducible enzyme that may down-regulate T cells by affecting local tryptophan catabolism in tumor resistance to repeated treatments with IFN gamma-NGR. The study was carried out in immunocompetent mice and in nu/nu mice bearing RMA lymphoma, B16F melanoma, or WEHI-164 fibrosarcoma and in vitro using cultured tumor cells. IDO activity was increased in lymphoma homogenates after multiple treatments with IFN gamma-NGR but not after a single treatment. Coadministration of 1-methyl-tryptophan, an inhibitor of IDO, increased tumor responses to multiple treatments in the lymphoma, melanoma, and fibrosarcoma models. No synergism between IFN gamma-NGR and 1-methyl-tryptophan was observed in vitro in tumor cell proliferation assays or in nu/nu tumor-bearing mice, suggesting that the antitumor effect was host mediated. We conclude that IDO is critically involved in tumor resistance to repeated treatments with IFN gamma-NGR, likely causing excessive stimulation of tryptophan catabolism and inhibiting antitumor immune mechanisms. Coadministration of IFN gamma-NGR with IDO inhibitors could represent a new strategy for increasing its antitumor activity. [Mol Cancer Ther 2008;7(12):3859-66]
引用
收藏
页码:3859 / 3866
页数:8
相关论文
共 49 条
  • [1] HUMAN INTERFERON-INDUCIBLE PROTEIN-10 IS A POTENT INHIBITOR OF ANGIOGENESIS IN-VIVO
    ANGIOLILLO, AL
    SGADARI, C
    TAUB, DD
    LIAO, F
    FARBER, JM
    MAHESHWARI, S
    KLEINMAN, HK
    REAMAN, GH
    TOSATO, G
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 182 (01) : 155 - 162
  • [2] INTERFERON-GAMMA FOR THE TREATMENT OF METASTATIC RENAL-CANCER - DOSE-DEPENDENT STIMULATION AND DOWN-REGULATION OF BETA-2 MICROGLOBULIN AND NEOPTERIN RESPONSES
    AULITZKY, W
    GASTL, G
    AULITZKY, WE
    NACHBAUR, K
    LANSKE, B
    KEMMLER, G
    FLENER, R
    FRICK, J
    HUBER, C
    [J]. IMMUNOBIOLOGY, 1987, 176 (1-2) : 85 - 95
  • [3] BANCROFT GJ, 1987, J IMMUNOL, V139, P1104
  • [4] BASHAM TY, 1983, J IMMUNOL, V130, P1492
  • [5] RECOMBINANT GAMMA INTERFERON DIFFERENTIALLY REGULATES CLASS-II ANTIGEN EXPRESSION AND BIOSYNTHESIS ON CULTURED NORMAL HUMAN KERATINOCYTES
    BASHAM, TY
    NICKOLOFF, BJ
    MERIGAN, TC
    MORHENN, VB
    [J]. JOURNAL OF INTERFERON RESEARCH, 1985, 5 (01): : 23 - 32
  • [6] Expression of indoleamine 2,3-dioxygenase (IDO) by endothelial cells: Implications for the control of alloresponses
    Beutelspacher, SC
    Tan, PH
    McClure, MO
    Larkin, DFP
    Lechler, RI
    George, AJT
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2006, 6 (06) : 1320 - 1330
  • [7] The role of IFN-γ in tumor transplantation immunity and inhibition of chemical carcinogenesis
    Blankenstein, T
    Qin, ZH
    [J]. CURRENT OPINION IN IMMUNOLOGY, 2003, 15 (02) : 148 - 154
  • [8] The neovasculature homing motif NGR: more than meets the eye
    Corti, Angelo
    Curnis, Flavio
    Arap, Wadih
    Pasqualini, Renata
    [J]. BLOOD, 2008, 112 (07) : 2628 - 2635
  • [9] Enhancement of tumor necrosis factor a antitumor immunotherapeutic properties by targeted delivery to aminopeptidase N (CD13)
    Curnis, F
    Sacchi, A
    Borgna, L
    Magni, F
    Gasparri, A
    Corti, A
    [J]. NATURE BIOTECHNOLOGY, 2000, 18 (11) : 1185 - 1190
  • [10] Targeted delivery of IFNγ to tumor vessels uncouples antitumor from counterregulatory mechanisms
    Curnis, F
    Gasparri, A
    Sacchi, A
    Cattaneo, A
    Magni, F
    Corti, A
    [J]. CANCER RESEARCH, 2005, 65 (07) : 2906 - 2913